4.7 Article

Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in vitro

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Obstetrics & Gynecology

Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review

Alessandro Favilli et al.

Summary: Clinical trials for COVID-19 treatment in pregnant women are lacking due to safety concerns, leading to a lack of knowledge on the effectiveness and safety of drugs used in the general population. This overview provides useful information for physicians on the management of COVID-19 during pregnancy in the current state of uncertainty and limited knowledge.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach

Kinjal Bhadresha et al.

Summary: This study identified theaflavin-3-gallate as a promising natural inhibitor of Hsp90, which can significantly inhibit cell proliferation, induce cell death, reduce cell migration and colony formation in breast cancer cells, and downregulate the expression of several related genes. This compound has the potential to improve the efficacy of existing breast cancer therapies and overall survival of patients.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Article Virology

Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India

Urvashi B. Singh et al.

Summary: This study analyzed the genomic profiles of breakthrough infections following vaccination with different vaccines, and found that variants of concern B.1.617.2 and B.1.1.7 were the predominant lineages causing a surge in cases in Delhi, India during April-May 2021.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Chemistry, Medicinal

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors

Sarah Huff et al.

Summary: This study identifies a class of compounds targeting the SARS-CoV-2 main protease that can inhibit viral replication. The compounds were found through medicinal chemistry and rational drug design strategies and offer a potential framework for the development of future COVID-19 treatments.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Virology

Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients

Zeinab Mohseni Afshar et al.

Summary: The Covid-19 pandemic has had devastating effects on global public health, but the deployment of vaccines has helped control the virus. While common side effects following vaccination are usually self-restricted, there have been rare cases of vaccine-induced thrombosis. This review summarizes thrombotic events after Covid-19 vaccination and provides a management plan, emphasizing the importance of vaccination to overcome the pandemic.

REVIEWS IN MEDICAL VIROLOGY (2022)

Article Biotechnology & Applied Microbiology

COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety

Katherine Kricorian et al.

Summary: The study found that people who perceived the COVID-19 vaccine as unsafe were less willing to receive it, had less knowledge about the virus, and were more likely to believe in vaccine myths. These individuals typically had lower education levels, income, and were more rural compared to those who believed the vaccine was safe.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Biochemistry & Molecular Biology

Natural-like products as potential SARS-CoV-2 Mproinhibitors:in-silicodrug discovery

Mahmoud A. A. Ibrahim et al.

Summary: The study utilized in-silico drug discovery approaches to identify nine potent natural-like products as potential inhibitors of SARS-CoV-2 main protease. Among these, four derivatives showed high binding affinities and stability in MD simulations, indicating their potential as drug candidates for COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation

Pallab Kar et al.

Summary: The study utilized computational methods to identify potential plant compounds with inhibitory effects on critical proteins of SARS-CoV-2, showing promise as therapeutic candidates for combating the virus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biology

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs

Vijay Kumar Bhardwaj et al.

Summary: The study identified DSPD-2, DSPD-6, and DSPD-5 as potential inhibitors of SARS-CoV-2 by efficiently binding to the S1 subsite of Mpro. Targeting molecules to bind effectively to the S1 subsite could potentially improve the binding of molecules to SARS-CoV-2 Mpro, suggesting a new approach for developing antiviral drugs.

COMPUTERS IN BIOLOGY AND MEDICINE (2021)

Review Cell Biology

Theaflavin Chemistry and Its Health Benefits

Zhiguo Shan et al.

Summary: TFs in black tea, particularly TF3, exhibit significant health benefits including anti-inflammatory, antioxidant, anticancer, antiobesity, antiosteoporotic, and antimicrobial properties, which have a significant impact on human health. Studies have shown that TFs play a crucial role in modulating health effects through cellular and molecular mechanisms.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Biochemistry & Molecular Biology

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors

Mahmoud A. A. Ibrahim et al.

Summary: This study identified a marine-derived metabolite called erylosides B as a promising anti-SARS-CoV-2 agent with stronger binding affinity to the virus's main protease than lopinavir, a human immunodeficiency virus protease inhibitor. This suggests that erylosides B could be a potential lead drug for combating COVID-19, highlighting the need for further in vitro and in vivo testing.

MOLECULES (2021)

Article Medicine, General & Internal

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman et al.

Summary: Despite evidence of vaccine efficacy, two fully vaccinated individuals developed mild symptoms of Covid-19 and were infected with variants of SARS-CoV-2. Sequencing of the virus isolates revealed novel mutations, highlighting the potential risk of illness post-vaccination and subsequent infection with variant virus. Efforts to prevent, diagnose, and characterize variants in vaccinated individuals are crucial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Chemistry, Applied

An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2

Jatin Sharma et al.

Summary: The research focused on screening and studying inhibitor molecules targeting Nsp15 has shown that bioactive molecules in tea (Barrigenol, Kaempferol, and Myricetin) may have potential antiviral effects, warranting further investigation and validation.

FOOD CHEMISTRY (2021)

Letter Infectious Diseases

Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India

J. Beena Philomina et al.

JOURNAL OF INFECTION (2021)

Article Biochemical Research Methods

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

Mahmoud A. A. Ibrahim et al.

Summary: COVID-19 is a new pandemic caused by SARS-CoV-2, and current therapies are limited. Flavonoids, especially rutin, have shown potential as inhibitors of the SARS-CoV-2 M-pro. Screening of 371 flavone analogs revealed two with better binding affinities than rutin, suggesting they may be promising drug candidates for further research.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)

Article Virology

Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice

Tarlan Mamedov et al.

Summary: The study demonstrated the successful production of SARS-CoV-2 RBD protein in plants, which elicited specific antibodies with potent virus-neutralizing activity in mice. This plant-produced glycosylated and deglycosylated RBD antigens are promising vaccine candidates for COVID-19 prevention.

VIRUSES-BASEL (2021)

Article Biochemistry & Molecular Biology

Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor

Jinbiao Liu et al.

Summary: The study demonstrated that green tea beverage or its major ingredient, epigallocatechin gallate (EGCG), were highly effective in inhibiting live SARS-CoV-2 and human coronavirus infection, especially against new variants. Among the 4 active green tea catechins, EGCG showed the strongest antiviral effect by interfering with the binding of viral spikes to host cell receptors.

CELL AND BIOSCIENCE (2021)

Article Medicine, General & Internal

Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2

Vijay Kumar Bhardwaj et al.

Summary: COVID-19, caused by SARS-CoV-2, lacks specific therapeutics, prompting research on utilizing bioactive molecules from tea to target the virus. Three tea-derived compounds show promising interactions with key viral enzymes, suggesting potential as treatment options for COVID-19.

FRONTIERS IN MEDICINE (2021)

Article Public, Environmental & Occupational Health

SARS-CoV-2 re-infection: development of an epidemiological definition from India

Aparna Mukherjee et al.

Summary: This study aimed to develop an epidemiological case definition of SARS-CoV-2 re-infection and assess its magnitude in India. Through an archive-based, telephonic survey, 4.5% of infected individuals were found to have experienced re-infection, with the majority being asymptomatic and healthcare workers accounting for 31.6% of the cases.

EPIDEMIOLOGY AND INFECTION (2021)

Article Biochemistry & Molecular Biology

Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective

Rahul Singh et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Immunology

Forty years with coronaviruses

Susan R. Weiss

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Ahmad Abu Turab Naqvi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Computer Science, Interdisciplinary Applications

Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase

Vijay Kumar Bhardwaj et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2020)

Article Integrative & Complementary Medicine

Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro

Minsu Jang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)

Article Chemistry, Medicinal

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2

Mohammad M. Ghahremanpour et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Biology

In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors

Mahmoud A. A. Ibrahim et al.

COMPUTERS IN BIOLOGY AND MEDICINE (2020)

Article Biochemistry & Molecular Biology

Lessons learned about steered molecular dynamics simulations and free energy calculations

Fernando Martin Boubeta et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2019)

Article Biochemistry & Molecular Biology

PubChem Substance and Compound databases

Sunghwan Kim et al.

NUCLEIC ACIDS RESEARCH (2016)

Review Chemistry, Multidisciplinary

Calculating protein-ligand binding affinities with MMPBSA: Method and error analysis

Changhao Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2016)

Article Chemistry, Medicinal

g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations

Rashmi Kumari et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)

Article Virology

Coronaviruses: Important Emerging Human Pathogens

Christopher M. Coleman et al.

JOURNAL OF VIROLOGY (2014)

Article Chemistry, Multidisciplinary

Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations

Wenbo Yu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

Review Toxicology

Antioxidative and anti-carcinogenic activities of tea polyphenols

Chung S. Yang et al.

ARCHIVES OF TOXICOLOGY (2009)

Review Pharmacology & Pharmacy

Natural products in drug discovery

Alan L. Harvey

DRUG DISCOVERY TODAY (2008)

Article Chemistry, Physical

GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation

Berk Hess et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)

Article Biochemistry & Molecular Biology

HMDB: the human metabolome database

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2007)

Review Chemistry, Multidisciplinary

GROMACS: Fast, flexible, and free

D Van der Spoel et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Agriculture, Multidisciplinary

Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro

M Nakai et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Antiviral flavonoids from the root bark of Morus alba L.

J Du et al.

PHYTOCHEMISTRY (2003)